-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
TScan Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2021 to Q2 2024.
- TScan Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -59.8 %, a 11.1% increase year-over-year.
- TScan Therapeutics, Inc. annual Return On Equity for 2023 was -60.7 %, a 13% decline from 2022.
- TScan Therapeutics, Inc. annual Return On Equity for 2022 was -53.7 %, a 37.9% increase from 2021.
- TScan Therapeutics, Inc. annual Return On Equity for 2021 was -86.5 %, a 205% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)